Refined By:
Subject:  diabetes

Results 1-7 of 7 (Search time: 0.002 seconds).

Issue DateTitleAuthor(s)
11-Jan-2015An advanced microencapsulated system: A platform for optimized oral delivery of antidiabetic drug-bile acid formulationsMooranian A.; Negrulj R.; Mathavan S.; Martinez J.; Sciarretta J.; Chen-Tan N.; Mukkur T.; Momir Mikov ; Mladena Lalić-Popović ; Maja Stojančević; Svetlana Goločorbin-Kon ; Al-Salami H.
21-Jan-2008The influence of 3α,7α-dihydroxy-12-keto-5β-cholanate on gliclazide pharmacokinetics and glucose levels in a rat model of diabetesMomir Mikov ; Hani Al-Salami; Svetlana Goločorbin-Kon ; Ranko Škrbić; Aleksandar Rašković ; Paul J. Fawcett
39-Sep-2014Microencapsulation as a novel delivery method for the potential antidiabetic drug, ProbucolMooranian A.; Negrulj R.; Chen-Tan N.; Al-Sallami H.; Fang Z.; Mukkur T.; Momir Mikov ; Svetlana Goločorbin-Kon ; Fakhoury M.; Watts G.; Matthews V.; Arfuso F.; Al-Salami H.
412-Nov-2018Novel nano-encapsulation of probucol in microgels: scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analysesArmin Mooranian; Nassim Zamani; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Frank Arfuso; Hani Al-Salami
55-Jun-2020Pharmacological Effects of Secondary Bile Acid Microparticles in Diabetic Murine ModelArmin Mooranian; Nassim Zamani; Božica Kovačević; Corina Mihaela Ionescu; Giuseppe Luna; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Sanja Kojić ; Hani Al-Salami
61-Jan-2019Probucol-poly(meth)acrylate-bile acid nanoparticles increase IL-10, and primary bile acids in prediabetic miceMooranian A.; Zamani N.; Takechi R.; Al-Sallami H.; Momir Mikov ; Svetlana Goločorbin-Kon ; Božica Kovačević; Arfuso F.; Al-Salami H.
71-Jan-2015Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatmentMooranian A.; Negrulj R.; Al-Sallami H.; Fang Z.; Momir Mikov ; Svetlana Goločorbin-Kon ; Fakhoury M.; Aruso F.; Al-Salami H.